Docetaxel Treatment in Castration-Resistant Prostate Cancer: the Triad Gene-Drug-Disease

Fabio Rueda Faucz

doi:10.1210/jc.2010-2875

Docetaxel Treatment in Castration-Resistant Prostate Cancer: the Triad Gene-Drug-Disease

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2010-2875 ◽

2011 ◽

Vol 96 (2) ◽

pp. 351-353 ◽

Cited By ~ 1

Author(s):

Fabio Rueda Faucz

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Docetaxel Treatment

Download Full-text

Faculty Opinions recommendation of Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.5686956.10860058 ◽

2011 ◽

Author(s):

Cora Sternberg ◽

Linda Cerbone

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Open Label ◽

Castration Resistant ◽

Docetaxel Treatment ◽

Open Label Trial

Download Full-text

PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: Multicenter validation in patients from the Chinese Prostate Cancer Consortium

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2019.07.014 ◽

2020 ◽

Vol 38 (1) ◽

pp. 2.e11-2.e17 ◽

Cited By ~ 2

Author(s):

Xinqi Pei ◽

Kaijie Wu ◽

Yinghao Sun ◽

Xu Gao ◽

Xin Gou ◽

...

Keyword(s):

Prostate Cancer ◽

Prognostic Factor ◽

Castration Resistant Prostate Cancer ◽

First Line ◽

Castration Resistant ◽

Docetaxel Treatment ◽

Multicenter Validation

Download Full-text

346 KLK3, PCA3 and TMPRSS2-ERG expression in peripheral blood mononuclear cells from castration-resistant prostate cancer patients and response to docetaxel treatment

European Urology Supplements ◽

10.1016/s1569-9056(14)60341-9 ◽

2014 ◽

Vol 13 (1) ◽

pp. e346

Author(s):

S. Dijkstra ◽

G.H.J.M. Leyten ◽

S.A. Jannink ◽

H. De Jong ◽

P.F.A. Mulders ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Peripheral Blood Mononuclear Cells ◽

Peripheral Blood ◽

Mononuclear Cells ◽

Castration Resistant Prostate Cancer ◽

Peripheral Blood Mononuclear ◽

Castration Resistant ◽

Blood Mononuclear Cells ◽

Docetaxel Treatment

Download Full-text

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

The Lancet ◽

10.1016/s0140-6736(10)61389-x ◽

2010 ◽

Vol 376 (9747) ◽

pp. 1147-1154 ◽

Cited By ~ 1926

Author(s):

Johann Sebastian de Bono ◽

Stephane Oudard ◽

Mustafa Ozguroglu ◽

Steinbjørn Hansen ◽

Jean-Pascal Machiels ◽

...

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Open Label ◽

Castration Resistant ◽

Docetaxel Treatment ◽

Open Label Trial

Download Full-text

Re: Prednisone Plus Cabazitaxel or Mitoxantrone for Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel Treatment: A Randomised Open-Label Trial

European Urology ◽

10.1016/j.eururo.2011.01.021 ◽

2011 ◽

Vol 59 (4) ◽

pp. 658 ◽

Cited By ~ 3

Author(s):

Philippe Beuzeboc

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Open Label ◽

Castration Resistant ◽

Docetaxel Treatment ◽

Open Label Trial

Download Full-text

Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e16034 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e16034-e16034

Author(s):

Luis Leon Mateos ◽

Laura Muinelo ◽

Begoña Perez-Valderrama ◽

Begoña Mellado ◽

María José Juan Fita ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Tumour Cell ◽

Phase Ii Study ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Docetaxel Treatment ◽

Circulating Tumour Cell

Download Full-text

Re: Prednisone Plus Cabazitaxel or Mitoxantrone for Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel Treatment: A Randomized Open-Label Trial

European Urology ◽

10.1016/j.eururo.2011.01.022 ◽

2011 ◽

Vol 59 (4) ◽

pp. 659 ◽

Cited By ~ 1

Author(s):

Dieter Jocham ◽

Martin Sommerauer

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Open Label ◽

Castration Resistant ◽

Docetaxel Treatment ◽

Open Label Trial

Download Full-text

KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment

The Prostate ◽

10.1002/pros.22839 ◽

2014 ◽

Vol 74 (12) ◽

pp. 1222-1230 ◽

Cited By ~ 20

Author(s):

Siebren Dijkstra ◽

Gisele H. J. M. Leyten ◽

Sander A. Jannink ◽

Hans de Jong ◽

Peter F. A. Mulders ◽

...

Keyword(s):

Prostate Cancer ◽

Peripheral Blood Mononuclear Cell ◽

Cancer Patients ◽

Mononuclear Cell ◽

Peripheral Blood ◽

Castration Resistant Prostate Cancer ◽

Peripheral Blood Mononuclear ◽

Castration Resistant ◽

Docetaxel Treatment ◽

Mononuclear Cell Fraction

Download Full-text

S203 The impact of body mass index on the response to docetaxel treatment in patients with metastatic castration-resistant prostate cancer

European Urology Supplements ◽

10.1016/s1569-9056(13)62236-8 ◽

2013 ◽

Vol 12 (4) ◽

pp. e1311, S203

Author(s):

M. Culpan ◽

A. Yildirim ◽

S.K. Keskin ◽

E.K. Basok ◽

C. Canakci ◽

...

Keyword(s):

Prostate Cancer ◽

Body Mass Index ◽

Body Mass ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Docetaxel Treatment ◽

The Impact

Download Full-text

Faculty Opinions recommendation of Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.5686956.6060054 ◽

2010 ◽

Author(s):

Michael Glode ◽

Thomas Flaig

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Open Label ◽

Castration Resistant ◽

Docetaxel Treatment ◽

Open Label Trial

Download Full-text